BioSpace News Archive

Pharm Country

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction

September 17, 2021
·
43 min read
Pharm Country

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy for Certain Patients With Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1 (CPS ≥10)

Merck today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of KEYTRUDA

September 17, 2021
·
39 min read
Drug Development

Appili Therapeutics Announces Completion of Patient Enrollment for Avigan®/Reeqonus™ Viral Shedding Sub- Study for Mild-to-Moderate COVID-19 Patients

Appili Therapeutics Inc. today announced it has completed patient enrollment in the viral shedding sub-study portion of its Phase 3 PRESECO

September 17, 2021
·
8 min read
Business

DS-7300 Data at ESMO Shows Promising Early Clinical Activity in Patients with Advanced Solid Cancers

First-in-human dose escalation results from phase 1/2 study of DS-7300, Daiichi Sankyo’s fourth DXd ADC in clinical development, highlighted in Proffered Paper session at ESMO

September 17, 2021
·
8 min read
Drug Development

IMFINZI Combined With Novel Immunotherapies Improved Clinical Outcomes for Patients With Unresectable, Stage III Non-Small Cell Lung Cancer

Results from the large, randomized COAST Phase II trial showed oleclumab, an anti-CD73 monoclonal antibody, or monalizumab

September 17, 2021
·
22 min read
Bio NC

Humacyte Leadership to Present at Five Scientific Events in September

Humacyte, Inc. today announced that senior leadership will present at five scientific and medical events in September 2021.

September 17, 2021
·
7 min read
Alvotech Welcomes Positive CHMP Opinion for AVT02, a Proposed Biosimilar to Humira®

Alvotech today welcomed the positive opinion of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending the approval of Alvotech‘s high-concentration AVT02 (100 mg/mL), a proposed biosimilar to Humira® (adalimumab).

September 17, 2021
·
4 min read
Drug Development

ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021

ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021

September 17, 2021
·
7 min read
BioMidwest

CVRx Added to Russell 2000® and 3000® Indexes

CVRx, Inc. today announced it will be added as a member of the Russell 2000 ® and 3000 ® Indexes, effective after the U.S. market opens on September 20

September 17, 2021
·
3 min read
Biotech Bay

Applied Molecular Transport Announces Upcoming Investor Events in September and October

Applied Molecular Transport Inc. today announced that the company will participate in the following investor events in September and October.

September 17, 2021
·
2 min read